228 related articles for article (PubMed ID: 31461490)
1. Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans.
Keulen DV; Pouwer MG; Emilsson V; Matic LP; Pieterman EJ; Hedin U; Gudnason V; Jennings LL; Holmstrøm K; Nielsen BS; Pasterkamp G; Lindeman JHN; van Gool AJ; Sollewijn Gelpke MD; Princen HMG; Tempel D
PLoS One; 2019; 14(8):e0221477. PubMed ID: 31461490
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory cytokine oncostatin M induces endothelial activation in macro- and microvascular endothelial cells and in APOE*3Leiden.CETP mice.
van Keulen D; Pouwer MG; Pasterkamp G; van Gool AJ; Sollewijn Gelpke MD; Princen HMG; Tempel D
PLoS One; 2018; 13(10):e0204911. PubMed ID: 30273401
[TBL] [Abstract][Full Text] [Related]
3. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
Adrian-Segarra JM; Sreenivasan K; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 Dec; 293(52):20181-20199. PubMed ID: 30373773
[TBL] [Abstract][Full Text] [Related]
4. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
[TBL] [Abstract][Full Text] [Related]
5. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages.
Zhang X; Li J; Qin JJ; Cheng WL; Zhu X; Gong FH; She Z; Huang Z; Xia H; Li H
J Lipid Res; 2017 May; 58(5):895-906. PubMed ID: 28258089
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M pathway plays a major role in the renal acute phase response.
Luyckx VA; Cairo LV; Compston CA; Phan WL; Mueller TF
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F875-83. PubMed ID: 19158344
[TBL] [Abstract][Full Text] [Related]
8. A unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptor.
Chollangi S; Mather T; Rodgers KK; Ash JD
J Biol Chem; 2012 Sep; 287(39):32848-59. PubMed ID: 22829597
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma.
Kausar T; Sharma R; Hasan MR; Saraya A; Chattopadhyay TK; Gupta SD; Ralhan R
Cell Oncol (Dordr); 2011 Jun; 34(3):177-87. PubMed ID: 21394648
[TBL] [Abstract][Full Text] [Related]
10. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas.
Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC
J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353
[TBL] [Abstract][Full Text] [Related]
11. Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions.
Ruprecht K; Kuhlmann T; Seif F; Hummel V; Kruse N; Brück W; Rieckmann P
J Neuropathol Exp Neurol; 2001 Nov; 60(11):1087-98. PubMed ID: 11706938
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
West NR; Hegazy AN; Owens BMJ; Bullers SJ; Linggi B; Buonocore S; Coccia M; Görtz D; This S; Stockenhuber K; Pott J; Friedrich M; Ryzhakov G; Baribaud F; Brodmerkel C; Cieluch C; Rahman N; Müller-Newen G; Owens RJ; Kühl AA; Maloy KJ; Plevy SE; ; Keshav S; Travis SPL; Powrie F
Nat Med; 2017 May; 23(5):579-589. PubMed ID: 28368383
[TBL] [Abstract][Full Text] [Related]
13. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
[TBL] [Abstract][Full Text] [Related]
14. Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
Kucia-Tran JA; Tulkki V; Scarpini CG; Smith S; Wallberg M; Paez-Ribes M; Araujo AM; Botthoff J; Feeney M; Hughes K; Caffarel MM; Coleman N
J Pathol; 2018 Mar; 244(3):283-295. PubMed ID: 29205362
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M is expressed in atherosclerotic lesions: a role for Oncostatin M in the pathogenesis of atherosclerosis.
Albasanz-Puig A; Murray J; Preusch M; Coan D; Namekata M; Patel Y; Dong ZM; Rosenfeld ME; Wijelath ES
Atherosclerosis; 2011 Jun; 216(2):292-8. PubMed ID: 21376322
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
Underhill-Day N; Heath JK
Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts.
Foglia B; Sutti S; Pedicini D; Cannito S; Bocca C; Maggiora M; Bevacqua MR; Rosso C; Bugianesi E; Albano E; Novo E; Parola M
Cells; 2019 Dec; 9(1):. PubMed ID: 31861914
[TBL] [Abstract][Full Text] [Related]
18. Mice overexpressing murine oncostatin M (OSM) exhibit changes in hematopoietic and other organs that are distinct from those of mice overexpressing human OSM or bovine OSM.
Juan TS; Bolon B; Lindberg RA; Sun Y; Van G; Fletcher FA
Vet Pathol; 2009 Jan; 46(1):124-37. PubMed ID: 19112126
[TBL] [Abstract][Full Text] [Related]
19. The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice.
Landlinger C; Pouwer MG; Juno C; van der Hoorn JWA; Pieterman EJ; Jukema JW; Staffler G; Princen HMG; Galabova G
Eur Heart J; 2017 Aug; 38(32):2499-2507. PubMed ID: 28637178
[TBL] [Abstract][Full Text] [Related]
20. The inflammatory mediator oncostatin M induces angiopoietin 2 expression in endothelial cells in vitro and in vivo.
Rychli K; Kaun C; Hohensinner PJ; Rega G; Pfaffenberger S; Vyskocil E; Breuss JM; Furnkranz A; Uhrin P; Zaujec J; Niessner A; Maurer G; Huber K; Wojta J
J Thromb Haemost; 2010 Mar; 8(3):596-604. PubMed ID: 20088942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
